Breaking Through on Biosimilars

Take a deep dive into the policy and regulatory challenges facing the biosimilars market in the United States. We will discuss the significant role biosimilars have played in increasing patient access to more affordable medicines and factors affecting the future of sustainable biosimilar competition and development. Additionally, a diverse group of stakeholders will share their perspectives on the evolving biosimilars marketplace.

Who should attend:

Possible job titles include:
Regulatory Affairs, Medical Affairs, Business Development, Program Management, Policy, Commercial Development, Scientific Affairs, Research Analyst

About GRx+Biosims 2022

GRx+Biosims 2022 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development; the regulatory process and approvals; and the evolving policy landscape.